Industry Research Reports

Home > Reports > Chemical & Material > Global Roflumilast API Market Research Report 2026

Global Roflumilast API Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-04-18

Pages: 142 Pages

Report ld: 6502912

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Roflumilast API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Roflumilast API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Roflumilast API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Roflumilast API. The Roflumilast API market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Roflumilast API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Roflumilast API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Huateng Pharma
Chongqing Huapont Pharmaceutical
Interquim SA
Veranova
ALP Pharm
Aspire Lifesciences
Aurobindo Pharma Limited
Glenmark Pharmaceuticals
MSN Laboratories
Melody Healthcare
Mylan Inc
Torrent Pharmaceuticals

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

0.98
0.99
Others

Segment by Application

Medical Pharmaceutical
Scientific Research

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Roflumilast API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.

Chapter 3: Examines Roflumilast API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.

Chapter 4: Analyzes Roflumilast API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.

Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.

Chapter 8: Reviews the industry value chain, including upstream and downstream segments.

Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 10: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Roflumilast API Market Overview

1.1 Product Definition

1.2 Roflumilast API by Type

1.2.1 Global Roflumilast API Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 0.98

1.2.3 0.99

1.2.4 Others

1.3 Roflumilast API by Application

1.3.1 Global Roflumilast API Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Medical Pharmaceutical

1.3.3 Scientific Research

1.4 Global Market Growth Prospects

1.4.1 Global Roflumilast API Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Roflumilast API Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Roflumilast API Production Estimates and Forecasts (2021–2032)

1.4.4 Global Roflumilast API Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Roflumilast API Production Market Share by Manufacturers (2021–2026)

2.2 Global Roflumilast API Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Roflumilast API, Industry Ranking, 2024 vs 2025

2.4 Global Roflumilast API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Roflumilast API Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Roflumilast API, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Roflumilast API, Product Offerings and Applications

2.8 Global Key Manufacturers of Roflumilast API, Date of Entry into the Industry

2.9 Roflumilast API Market Competitive Situation and Trends

2.9.1 Roflumilast API Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Roflumilast API Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Roflumilast API Production by Region

3.1 Global Roflumilast API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Roflumilast API Production Value by Region (2021–2032)

3.2.1 Global Roflumilast API Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Roflumilast API by Region (2027–2032)

3.3 Global Roflumilast API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Roflumilast API Production Volume by Region (2021–2032)

3.4.1 Global Roflumilast API Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Roflumilast API by Region (2027–2032)

3.5 Global Roflumilast API Market Price Analysis by Region (2021–2032)

3.6 Global Roflumilast API Production, Value, and Year-over-Year Growth

3.6.1 North America Roflumilast API Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Roflumilast API Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Roflumilast API Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Roflumilast API Production Value Estimates and Forecasts (2021–2032)

4 Roflumilast API Consumption by Region

4.1 Global Roflumilast API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Roflumilast API Consumption by Region (2021–2032)

4.2.1 Global Roflumilast API Consumption by Region (2021–2026)

4.2.2 Global Roflumilast API Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Roflumilast API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Roflumilast API Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Roflumilast API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Roflumilast API Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Roflumilast API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Roflumilast API Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Roflumilast API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Roflumilast API Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Roflumilast API Production by Type (2021–2032)

5.1.1 Global Roflumilast API Production by Type (2021–2026)

5.1.2 Global Roflumilast API Production by Type (2027–2032)

5.1.3 Global Roflumilast API Production Market Share by Type (2021–2032)

5.2 Global Roflumilast API Production Value by Type (2021–2032)

5.2.1 Global Roflumilast API Production Value by Type (2021–2026)

5.2.2 Global Roflumilast API Production Value by Type (2027–2032)

5.2.3 Global Roflumilast API Production Value Market Share by Type (2021–2032)

5.3 Global Roflumilast API Price by Type (2021–2032)

6 Segment by Application

6.1 Global Roflumilast API Production by Application (2021–2032)

6.1.1 Global Roflumilast API Production by Application (2021–2026)

6.1.2 Global Roflumilast API Production by Application (2027–2032)

6.1.3 Global Roflumilast API Production Market Share by Application (2021–2032)

6.2 Global Roflumilast API Production Value by Application (2021–2032)

6.2.1 Global Roflumilast API Production Value by Application (2021–2026)

6.2.2 Global Roflumilast API Production Value by Application (2027–2032)

6.2.3 Global Roflumilast API Production Value Market Share by Application (2021–2032)

6.3 Global Roflumilast API Price by Application (2021–2032)

7 Key Companies Profiled

7.1 Huateng Pharma

7.1.1 Huateng Pharma Roflumilast API Company Information

7.1.2 Huateng Pharma Roflumilast API Product Portfolio

7.1.3 Huateng Pharma Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Huateng Pharma Main Business and Markets Served

7.1.5 Huateng Pharma Recent Developments/Updates

7.2 Chongqing Huapont Pharmaceutical

7.2.1 Chongqing Huapont Pharmaceutical Roflumilast API Company Information

7.2.2 Chongqing Huapont Pharmaceutical Roflumilast API Product Portfolio

7.2.3 Chongqing Huapont Pharmaceutical Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 Chongqing Huapont Pharmaceutical Main Business and Markets Served

7.2.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates

7.3 Interquim SA

7.3.1 Interquim SA Roflumilast API Company Information

7.3.2 Interquim SA Roflumilast API Product Portfolio

7.3.3 Interquim SA Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 Interquim SA Main Business and Markets Served

7.3.5 Interquim SA Recent Developments/Updates

7.4 Veranova

7.4.1 Veranova Roflumilast API Company Information

7.4.2 Veranova Roflumilast API Product Portfolio

7.4.3 Veranova Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Veranova Main Business and Markets Served

7.4.5 Veranova Recent Developments/Updates

7.5 ALP Pharm

7.5.1 ALP Pharm Roflumilast API Company Information

7.5.2 ALP Pharm Roflumilast API Product Portfolio

7.5.3 ALP Pharm Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 ALP Pharm Main Business and Markets Served

7.5.5 ALP Pharm Recent Developments/Updates

7.6 Aspire Lifesciences

7.6.1 Aspire Lifesciences Roflumilast API Company Information

7.6.2 Aspire Lifesciences Roflumilast API Product Portfolio

7.6.3 Aspire Lifesciences Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 Aspire Lifesciences Main Business and Markets Served

7.6.5 Aspire Lifesciences Recent Developments/Updates

7.7 Aurobindo Pharma Limited

7.7.1 Aurobindo Pharma Limited Roflumilast API Company Information

7.7.2 Aurobindo Pharma Limited Roflumilast API Product Portfolio

7.7.3 Aurobindo Pharma Limited Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 Aurobindo Pharma Limited Main Business and Markets Served

7.7.5 Aurobindo Pharma Limited Recent Developments/Updates

7.8 Glenmark Pharmaceuticals

7.8.1 Glenmark Pharmaceuticals Roflumilast API Company Information

7.8.2 Glenmark Pharmaceuticals Roflumilast API Product Portfolio

7.8.3 Glenmark Pharmaceuticals Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 Glenmark Pharmaceuticals Main Business and Markets Served

7.8.5 Glenmark Pharmaceuticals Recent Developments/Updates

7.9 MSN Laboratories

7.9.1 MSN Laboratories Roflumilast API Company Information

7.9.2 MSN Laboratories Roflumilast API Product Portfolio

7.9.3 MSN Laboratories Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 MSN Laboratories Main Business and Markets Served

7.9.5 MSN Laboratories Recent Developments/Updates

7.10 Melody Healthcare

7.10.1 Melody Healthcare Roflumilast API Company Information

7.10.2 Melody Healthcare Roflumilast API Product Portfolio

7.10.3 Melody Healthcare Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 Melody Healthcare Main Business and Markets Served

7.10.5 Melody Healthcare Recent Developments/Updates

7.11 Mylan Inc

7.11.1 Mylan Inc Roflumilast API Company Information

7.11.2 Mylan Inc Roflumilast API Product Portfolio

7.11.3 Mylan Inc Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.11.4 Mylan Inc Main Business and Markets Served

7.11.5 Mylan Inc Recent Developments/Updates

7.12 Torrent Pharmaceuticals

7.12.1 Torrent Pharmaceuticals Roflumilast API Company Information

7.12.2 Torrent Pharmaceuticals Roflumilast API Product Portfolio

7.12.3 Torrent Pharmaceuticals Roflumilast API Production, Value, Price, and Gross Margin (2021–2026)

7.12.4 Torrent Pharmaceuticals Main Business and Markets Served

7.12.5 Torrent Pharmaceuticals Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Roflumilast API Industry Chain Analysis

8.2 Roflumilast API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Roflumilast API Production Modes and Processes

8.4 Roflumilast API Sales and Marketing

8.4.1 Roflumilast API Sales Channels

8.4.2 Roflumilast API Distributors

8.5 Roflumilast API Customer Analysis

9 Roflumilast API Market Dynamics

9.1 Roflumilast API Industry Trends

9.2 Roflumilast API Market Drivers

9.3 Roflumilast API Market Challenges

9.4 Roflumilast API Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Roflumilast API Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Roflumilast API Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Roflumilast API Production Capacity (Tons) by Manufacturers in 2025

Table 4. Global Roflumilast API Production by Manufacturers (Tons), 2021–2026

Table 5. Global Roflumilast API Production Market Share by Manufacturers (2021–2026)

Table 6. Global Roflumilast API Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Roflumilast API Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Roflumilast API, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Roflumilast API Production Value, 2025

Table 10. Global Market Roflumilast API Average Price by Manufacturers (US$/Kg), 2021–2026

Table 11. Global Key Manufacturers of Roflumilast API, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Roflumilast API, Product Offerings and Applications

Table 13. Global Key Manufacturers of Roflumilast API, Date of Entry into the Industry

Table 14. Global Roflumilast API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Roflumilast API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Roflumilast API Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Roflumilast API Production Value Market Share by Region (2021–2026)

Table 19. Global Roflumilast API Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Roflumilast API Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Roflumilast API Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)

Table 22. Global Roflumilast API Production (Tons) by Region (2021–2026)

Table 23. Global Roflumilast API Production Market Share by Region (2021–2026)

Table 24. Global Roflumilast API Production (Tons) Forecast by Region (2027–2032)

Table 25. Global Roflumilast API Production Market Share Forecast by Region (2027–2032)

Table 26. Global Roflumilast API Market Average Price (US$/Kg) by Region (2021–2026)

Table 27. Global Roflumilast API Market Average Price (US$/Kg) by Region (2027–2032)

Table 28. Global Roflumilast API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)

Table 29. Global Roflumilast API Consumption by Region (Tons), 2021–2026

Table 30. Global Roflumilast API Consumption Market Share by Region (2021–2026)

Table 31. Global Roflumilast API Forecasted Consumption by Region (Tons), 2027–2032

Table 32. Global Roflumilast API Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Roflumilast API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 34. North America Roflumilast API Consumption by Country (Tons), 2021–2026

Table 35. North America Roflumilast API Consumption by Country (Tons), 2027–2032

Table 36. Europe Roflumilast API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 37. Europe Roflumilast API Consumption by Country (Tons), 2021–2026

Table 38. Europe Roflumilast API Consumption by Country (Tons), 2027–2032

Table 39. Asia Pacific Roflumilast API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)

Table 40. Asia Pacific Roflumilast API Consumption by Region (Tons), 2021–2026

Table 41. Asia Pacific Roflumilast API Consumption by Region (Tons), 2027–2032

Table 42. Latin America, Middle East & Africa Roflumilast API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 43. Latin America, Middle East & Africa Roflumilast API Consumption by Country (Tons), 2021–2026

Table 44. Latin America, Middle East & Africa Roflumilast API Consumption by Country (Tons), 2027–2032

Table 45. Global Roflumilast API Production (Tons) by Type (2021–2026)

Table 46. Global Roflumilast API Production (Tons) by Type (2027–2032)

Table 47. Global Roflumilast API Production Market Share by Type (2021–2026)

Table 48. Global Roflumilast API Production Market Share by Type (2027–2032)

Table 49. Global Roflumilast API Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Roflumilast API Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Roflumilast API Production Value Market Share by Type (2021–2026)

Table 52. Global Roflumilast API Production Value Market Share by Type (2027–2032)

Table 53. Global Roflumilast API Price (US$/Kg) by Type (2021–2026)

Table 54. Global Roflumilast API Price (US$/Kg) by Type (2027–2032)

Table 55. Global Roflumilast API Production (Tons) by Application (2021–2026)

Table 56. Global Roflumilast API Production (Tons) by Application (2027–2032)

Table 57. Global Roflumilast API Production Market Share by Application (2021–2026)

Table 58. Global Roflumilast API Production Market Share by Application (2027–2032)

Table 59. Global Roflumilast API Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Roflumilast API Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Roflumilast API Production Value Market Share by Application (2021–2026)

Table 62. Global Roflumilast API Production Value Market Share by Application (2027–2032)

Table 63. Global Roflumilast API Price (US$/Kg) by Application (2021–2026)

Table 64. Global Roflumilast API Price (US$/Kg) by Application (2027–2032)

Table 65. Huateng Pharma Roflumilast API Company Information

Table 66. Huateng Pharma Roflumilast API Specification and Application

Table 67. Huateng Pharma Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 68. Huateng Pharma Main Business and Markets Served

Table 69. Huateng Pharma Recent Developments/Updates

Table 70. Chongqing Huapont Pharmaceutical Roflumilast API Company Information

Table 71. Chongqing Huapont Pharmaceutical Roflumilast API Specification and Application

Table 72. Chongqing Huapont Pharmaceutical Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 73. Chongqing Huapont Pharmaceutical Main Business and Markets Served

Table 74. Chongqing Huapont Pharmaceutical Recent Developments/Updates

Table 75. Interquim SA Roflumilast API Company Information

Table 76. Interquim SA Roflumilast API Specification and Application

Table 77. Interquim SA Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 78. Interquim SA Main Business and Markets Served

Table 79. Interquim SA Recent Developments/Updates

Table 80. Veranova Roflumilast API Company Information

Table 81. Veranova Roflumilast API Specification and Application

Table 82. Veranova Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 83. Veranova Main Business and Markets Served

Table 84. Veranova Recent Developments/Updates

Table 85. ALP Pharm Roflumilast API Company Information

Table 86. ALP Pharm Roflumilast API Specification and Application

Table 87. ALP Pharm Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 88. ALP Pharm Main Business and Markets Served

Table 89. ALP Pharm Recent Developments/Updates

Table 90. Aspire Lifesciences Roflumilast API Company Information

Table 91. Aspire Lifesciences Roflumilast API Specification and Application

Table 92. Aspire Lifesciences Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 93. Aspire Lifesciences Main Business and Markets Served

Table 94. Aspire Lifesciences Recent Developments/Updates

Table 95. Aurobindo Pharma Limited Roflumilast API Company Information

Table 96. Aurobindo Pharma Limited Roflumilast API Specification and Application

Table 97. Aurobindo Pharma Limited Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 98. Aurobindo Pharma Limited Main Business and Markets Served

Table 99. Aurobindo Pharma Limited Recent Developments/Updates

Table 100. Glenmark Pharmaceuticals Roflumilast API Company Information

Table 101. Glenmark Pharmaceuticals Roflumilast API Specification and Application

Table 102. Glenmark Pharmaceuticals Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 103. Glenmark Pharmaceuticals Main Business and Markets Served

Table 104. Glenmark Pharmaceuticals Recent Developments/Updates

Table 105. MSN Laboratories Roflumilast API Company Information

Table 106. MSN Laboratories Roflumilast API Specification and Application

Table 107. MSN Laboratories Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 108. MSN Laboratories Main Business and Markets Served

Table 109. MSN Laboratories Recent Developments/Updates

Table 110. Melody Healthcare Roflumilast API Company Information

Table 111. Melody Healthcare Roflumilast API Specification and Application

Table 112. Melody Healthcare Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 113. Melody Healthcare Main Business and Markets Served

Table 114. Melody Healthcare Recent Developments/Updates

Table 115. Mylan Inc Roflumilast API Company Information

Table 116. Mylan Inc Roflumilast API Specification and Application

Table 117. Mylan Inc Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 118. Mylan Inc Main Business and Markets Served

Table 119. Mylan Inc Recent Developments/Updates

Table 120. Torrent Pharmaceuticals Roflumilast API Company Information

Table 121. Torrent Pharmaceuticals Roflumilast API Specification and Application

Table 122. Torrent Pharmaceuticals Roflumilast API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 123. Torrent Pharmaceuticals Main Business and Markets Served

Table 124. Torrent Pharmaceuticals Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Roflumilast API Distributors List

Table 128. Roflumilast API Customers List

Table 129. Roflumilast API Market Trends

Table 130. Roflumilast API Market Drivers

Table 131. Roflumilast API Market Challenges

Table 132. Roflumilast API Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Roflumilast API

Figure 2. Global Roflumilast API Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Roflumilast API Market Share by Type: 2025 vs 2032

Figure 4. 0.98 Product Picture

Figure 5. 0.99 Product Picture

Figure 6. Others Product Picture

Figure 7. Global Roflumilast API Market Value by Application (US$ Million), 2021–2032

Figure 8. Global Roflumilast API Market Share by Application: 2025 vs 2032

Figure 9. Medical Pharmaceutical

Figure 10. Scientific Research

Figure 11. Global Roflumilast API Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Roflumilast API Production Value (US$ Million), 2021–2032

Figure 13. Global Roflumilast API Production Capacity (Tons), 2021–2032

Figure 14. Global Roflumilast API Production (Tons), 2021–2032

Figure 15. Global Roflumilast API Average Price (US$/Kg), 2021–2032

Figure 16. Roflumilast API Report Years Considered

Figure 17. Roflumilast API Production Share by Manufacturers in 2025

Figure 18. Global Roflumilast API Production Value Share by Manufacturers (2025)

Figure 19. Roflumilast API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Top 5 and Top 10 Global Players: Market Share by Roflumilast API Revenue in 2025

Figure 21. Global Roflumilast API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 22. Global Roflumilast API Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 23. Global Roflumilast API Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)

Figure 24. Global Roflumilast API Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 25. North America Roflumilast API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 26. Europe Roflumilast API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. China Roflumilast API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. Japan Roflumilast API Production Value (US$ Million) Growth Rate (2021–2032)

Figure 29. Global Roflumilast API Consumption by Region: 2021 vs 2025 vs 2032 (Tons)

Figure 30. Global Roflumilast API Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 31. North America Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 32. North America Roflumilast API Consumption Market Share by Country (2021–2032)

Figure 33. U.S. Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 34. Canada Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 35. Europe Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 36. Europe Roflumilast API Consumption Market Share by Country (2021–2032)

Figure 37. Germany Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 38. France Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 39. U.K. Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 40. Italy Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 41. Russia Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 42. Asia Pacific Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 43. Asia Pacific Roflumilast API Consumption Market Share by Region (2021–2032)

Figure 44. China Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 45. Japan Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 46. South Korea Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 47. China Taiwan Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 48. Southeast Asia Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 49. India Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 50. Latin America, Middle East & Africa Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 51. Latin America, Middle East & Africa Roflumilast API Consumption Market Share by Country (2021–2032)

Figure 52. Mexico Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 53. Brazil Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 54. Turkey Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 55. GCC Countries Roflumilast API Consumption and Growth Rate (Tons), 2021–2032

Figure 56. Global Production Market Share of Roflumilast API by Type (2021–2032)

Figure 57. Global Production Value Market Share of Roflumilast API by Type (2021–2032)

Figure 58. Global Roflumilast API Price (US$/Kg) by Type (2021–2032)

Figure 59. Global Production Market Share of Roflumilast API by Application (2021–2032)

Figure 60. Global Production Value Market Share of Roflumilast API by Application (2021–2032)

Figure 61. Global Roflumilast API Price (US$/Kg) by Application (2021–2032)

Figure 62. Roflumilast API Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Roflumilast API market? zhanKai

The top companies in the global Roflumilast API market are Huateng Pharma、Chongqing Huapont Pharmaceutical、Interquim SA.

Related Reports

Roflumilast API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Roflumilast API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 144
USD 3950.00
(Single User License)
Global Roflumilast API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Roflumilast API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 92
USD 4250.00
(Single User License)
Global Roflumilast API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Roflumilast API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 162
USD 4900.00
(Single User License)
Roflumilast API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Roflumilast API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 126
USD 3950.00
(Single User License)
Global Roflumilast API Market Research Report 2025
The global market for Roflumilast API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 97
USD 2900.00
(Single User License)
Global Roflumilast API Market Research Report 2024
The global Roflumilast API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-07
Pages: 102
USD 2900.00
(Single User License)

Roflumilast API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Roflumilast API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 144
USD 3950.00 (Single User License)
Global Roflumilast API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Roflumilast API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 92
USD 4250.00 (Single User License)
Global Roflumilast API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Roflumilast API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 162
USD 4900.00 (Single User License)
Roflumilast API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Roflumilast API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 126
USD 3950.00 (Single User License)
Global Roflumilast API Market Research Report 2025
The global market for Roflumilast API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 97
USD 2900.00 (Single User License)
Global Roflumilast API Market Research Report 2024
The global Roflumilast API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-07
Pages: 102
USD 2900.00 (Single User License)